These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Expression of ADAM-17, TIMP-3 and fractalkine in the human adult brain endothelial cell line, hCMEC/D3, following pro-inflammatory cytokine treatment. Hurst LA; Bunning RA; Couraud PO; Romero IA; Weksler BB; Sharrack B; Woodroofe MN J Neuroimmunol; 2009 May; 210(1-2):108-12. PubMed ID: 19324423 [TBL] [Abstract][Full Text] [Related]
5. ADAM-17 and TIMP3 protein and mRNA expression in spinal cord white matter of rats with acute experimental autoimmune encephalomyelitis. Plumb J; Cross AK; Surr J; Haddock G; Smith T; Bunning RA; Woodroofe MN J Neuroimmunol; 2005 Jul; 164(1-2):1-9. PubMed ID: 15878627 [TBL] [Abstract][Full Text] [Related]
6. ADAM-10 and ADAM-17 in the inflamed human CNS. Kieseier BC; Pischel H; Neuen-Jacob E; Tourtellotte WW; Hartung HP Glia; 2003 Jun; 42(4):398-405. PubMed ID: 12730960 [TBL] [Abstract][Full Text] [Related]
7. CCR5 expression on macrophages/microglia is associated with early remyelination in multiple sclerosis lesions. Trebst C; König F; Ransohoff R; Brück W; Stangel M Mult Scler; 2008 Jul; 14(6):728-33. PubMed ID: 18611987 [TBL] [Abstract][Full Text] [Related]
8. Expression profiles of endoplasmic reticulum stress-related molecules in demyelinating lesions and multiple sclerosis. Cunnea P; Mháille AN; McQuaid S; Farrell M; McMahon J; FitzGerald U Mult Scler; 2011 Jul; 17(7):808-18. PubMed ID: 21382862 [TBL] [Abstract][Full Text] [Related]
9. Focal disturbances in the blood-brain barrier are associated with formation of neuroinflammatory lesions. Alvarez JI; Saint-Laurent O; Godschalk A; Terouz S; Briels C; Larouche S; Bourbonnière L; Larochelle C; Prat A Neurobiol Dis; 2015 Feb; 74():14-24. PubMed ID: 25448765 [TBL] [Abstract][Full Text] [Related]
10. Immunopathology of secondary-progressive multiple sclerosis. Prineas JW; Kwon EE; Cho ES; Sharer LR; Barnett MH; Oleszak EL; Hoffman B; Morgan BP Ann Neurol; 2001 Nov; 50(5):646-57. PubMed ID: 11706971 [TBL] [Abstract][Full Text] [Related]
11. Molecular signature of slowly expanding lesions in progressive multiple sclerosis. Jäckle K; Zeis T; Schaeren-Wiemers N; Junker A; van der Meer F; Kramann N; Stadelmann C; Brück W Brain; 2020 Jul; 143(7):2073-2088. PubMed ID: 32577755 [TBL] [Abstract][Full Text] [Related]
12. TACE mRNA expression in peripheral mononudear cells precedes new lesions on MRI in multiple sclerosis. Seifert T; Kieseier BC; Ropele S; Strasser-Fuchs S; Quehenberger F; Fazekas F; Hartung HP Mult Scler; 2002 Dec; 8(6):447-51. PubMed ID: 12474981 [TBL] [Abstract][Full Text] [Related]
13. Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions. Mehta V; Pei W; Yang G; Li S; Swamy E; Boster A; Schmalbrock P; Pitt D PLoS One; 2013; 8(3):e57573. PubMed ID: 23516409 [TBL] [Abstract][Full Text] [Related]
14. ADAMTS-1 and -4 are up-regulated following transient middle cerebral artery occlusion in the rat and their expression is modulated by TNF in cultured astrocytes. Cross AK; Haddock G; Stock CJ; Allan S; Surr J; Bunning RA; Buttle DJ; Woodroofe MN Brain Res; 2006 May; 1088(1):19-30. PubMed ID: 16630594 [TBL] [Abstract][Full Text] [Related]
15. Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions. Nijland PG; Michailidou I; Witte ME; Mizee MR; van der Pol SM; van Het Hof B; Reijerkerk A; Pellerin L; van der Valk P; de Vries HE; van Horssen J Glia; 2014 Jul; 62(7):1125-41. PubMed ID: 24692237 [TBL] [Abstract][Full Text] [Related]
16. Pathological basis of diffusely abnormal white matter: insights from magnetic resonance imaging and histology. Laule C; Vavasour IM; Leung E; Li DK; Kozlowski P; Traboulsee AL; Oger J; Mackay AL; Moore GR Mult Scler; 2011 Feb; 17(2):144-50. PubMed ID: 20965961 [TBL] [Abstract][Full Text] [Related]
17. Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Boven LA; Van Meurs M; Van Zwam M; Wierenga-Wolf A; Hintzen RQ; Boot RG; Aerts JM; Amor S; Nieuwenhuis EE; Laman JD Brain; 2006 Feb; 129(Pt 2):517-26. PubMed ID: 16364958 [TBL] [Abstract][Full Text] [Related]
19. The role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian study. Abo-Krysha N; Rashed L Mult Scler; 2008 Jun; 14(5):602-8. PubMed ID: 18408021 [TBL] [Abstract][Full Text] [Related]
20. Transglutaminase-6 is an autoantigen in progressive multiple sclerosis and is upregulated in reactive astrocytes. Cristofanilli M; Gratch D; Pagano B; McDermott K; Huang J; Jian J; Bates D; Sadiq SA Mult Scler; 2017 Nov; 23(13):1707-1715. PubMed ID: 28273770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]